The Global Virus Network: Challenging chikungunya

Antiviral Research

Volumn 120, Issue , 2015, Pages 147-152

  McSweegan, Edward ^a   Weaver, Scott C ^b   Lecuit, Marc ^c,d,e   Frieman, Matthew ^f   Morrison, Thomas E ^g   Hrynkow, Sharon ^a  

^a Global Virus Network   (United States)

^b Department of Pathology   (United States)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Arbovirus; Chikungunya; Emerging virus; Global Virus Network; Vector borne

Indexed keywords

ANTIVIRUS AGENT; CHIKUNGUNYA VACCINE; DNA VACCINE; LIVE VACCINE; RNA VACCINE; UNCLASSIFIED DRUG;

ARTHRALGIA; ARTICLE; BRAIN DISEASE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; DIGESTIVE SYSTEM DISEASE; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; GLOBAL VIRUS NETWORK; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEPATITIS; HUMAN; INFECTION PREVENTION; LYMPHADENOPATHY; MULTIPLE ORGAN FAILURE; MYALGIA; MYOCARDITIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PRURITUS; PUBLIC HEALTH; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VECTOR CONTROL; VIRUS TRANSMISSION; WESTERN HEMISPHERE; CHIKUNGUNYA FEVER; COMMUNICABLE DISEASE CONTROL; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; HEALTH; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT;

ARBOVIRUS; CHIKUNGUNYA VIRUS;

CHIKUNGUNYA FEVER; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION;

EID: 84934957173     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.06.003     Document Type: Review

References (39)

1. W. Akahata, Z.Y. Yang, H. Andersen, S. Sun, H.A. Holdaway, W.P. Kong, M.G. Lewis, S. Higgs, M.G. Rossmann, S. Rao, and G.J. Nabel A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection Nat. Med. 16 2010 334 338
2. I.C. Albulescu, A. Tas, F.E. Scholte, E.J. Snijder, and M.J. van Hemert An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors J. Gen. Virol. 95 2014 2683 2692
3. M. Bourjot, P. Leyssen, J. Neyts, V. Dumontet, and M. Litaudon Trigocherrierin A, a potent inhibitor of chikungunya virus replication Molecules 19 2014 3617 3627
4. S. Brandler, C. Ruffie, C. Combredet, J.B. Brault, V. Najburg, M.C. Prevost, A. Habel, E. Tauber, P. Despres, and F. Tangy A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus Vaccine 31 2013 3718 3725
5. L.J. Chang, K.A. Dowd, F.H. Mendoza, J.G. Saunders, S. Sitar, S.H. Plummer, G. Yamshchikov, U.N. Sarwar, Z. Hu, M.E. Enama, R.T. Bailer, R.A. Koup, R.M. Schwartz, W. Akahata, G.J. Nabel, J.R. Mascola, T.C. Pierson, B.S. Graham, J.E. Ledgerwood, and The V.R.C.S.T. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial Lancet 384 9959 2014 2046 2052
6. A. Chattopadhyay, E. Wang, R. Seymour, S.C. Weaver, and J.K. Rose A chimeric vesiculo/alphavirus is an effective alphavirus vaccine J. Virol. 87 2013 395 402
7. W. Chen, S.S. Foo, A. Taylor, A. Lulla, A. Merits, L. Hueston, M.R. Forwood, N.C. Walsh, N.A. Sims, L.J. Herrero, and S. Mahalingam Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection J. Virol. 89 2015 581 593
8. T. Couderc, F. Chretien, C. Schilte, O. Disson, M. Brigitte, F. Guivel-Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, P. Després, F. Arenzana-Seisdedos, A. Michault, M.L. Albert, and M. Lecuit A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease PLoS Pathog. 4 2 2008 e29
9. T. Couderc, N. Khandoudi, M. Grandadam, C. Visse, N. Gangeux, S. Bagot, J.F. Prost, and M. Lecuit Prophylaxis and therapy for Chikungunya virus infection J. Infect. Dis. 200 2009 516 523
10. R. Edelman, C.O. Tacket, S.S. Wasserman, S.A. Bodison, J.G. Perry, and J.A. Mangiafico Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218 Am. J. Trop. Med. Hyg. 62 2000 681 685
11. E.C. Farnon, J.J. Sejvar, and J.E. Staples Severe disease manifestations associated with Acute chikungunya virus infection Crit. Care Med. 36 9 2008 2682 2683
12. Gammon, K., 2014. The cost of chikungunya to Jamaica. Jamaica Observer, 20 Oct. < www.jamaicaobserver.com/columns/The-cost-of-chikungunya-to-Jamaica-17772229 > (accessed on April 7, 2015).
13. D. Hallengard, M. Kakoulidou, A. Lulla, B.M. Kummerer, D.X. Johansson, M. Mutso, V. Lulla, J.K. Fazakerley, P. Roques, R. Le Grand, A. Merits, and P. Liljeström Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice J. Virol. 88 2014 2858 2866
14. S.B. Halstead Reappearance of chikungunya, formerly called dengue, in the Americas Emerg. Infect. Dis. 21 2015 557 561
15. V.R. Harrison, K.H. Eckels, P.J. Bartelloni, and C. Hampton Production and evaluation of a formalin-killed Chikungunya vaccine J. Immunol. 107 1971 643 647
16. L. Josseran, C. Paquet, A. Zehgnoun, N. Caillere, A. le Tertre, J.-L. Solet, and M. Ledrans Chikungunya disease outbreak, Reunion Island Emerg. Infect. Dis. 12 2 2006 1994 1995
17. P. Kaur, M. Thiruchelvan, R.C. Lee, H. Chen, K.C. Chen, M.L. Ng, and J.J. Chu Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression Antimicrob. Agents Chemother. 57 2013 155 167
18. M. Khan, S.R. Santhosh, M. Tiwari, P.V. Lakshmana Rao, and M. Parida Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells J. Med. Virol. 82 2010 817 824
19. K. Labadie, T. Larcher, C. Joubert, A. Mannioui, B. Delache, P. Brochard, L. Guigand, L. Dubreil, P. Lebon, B. Verrier, X. de Lamballerie, A. Suhrbier, Y. Cherel, R. le Grand, and P. Roques Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages J. Clin. Invest. 120 3 2010 894 906
20. J. Lemant, V. Boisson, A. Winer, L. Thibault, H. André, F. Tixier, M. Lemercier, E. Antok, M.P. Cresta, P. Grivard, M. Besnard, O. Rollot, F. Favier, M. Huerre, J.L. Campinos, and A. Michault Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006 Crit. Care Med. 36 9 2008 2536 2541
21. N.H. Levitt, H.H. Ramsburg, S.E. Hasty, P.M. Repik, F.E. Cole, and H.W. Lupton Development of an attenuated strain of chikungunya virus for use in vaccine production Vaccine 4 1986 157 162
22. K. Mallilankaraman, D.J. Shedlock, H. Bao, O.U. Kawalekar, P. Fagone, A.A. Ramanathan, B. Ferraro, J. Stabenow, P. Vijayachari, S.G. Sundaram, N. Muruganandam, G. Sarangan, P. Srikanth, A.S. Khan, M.G. Lewis, J.J. Kim, N.Y. Sardesai, K. Muthumani, and D.B. Weiner A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates PLoS Negl. Trop. Dis. 5 2011 e928
23. D. Mavalankar, P. Shastri, T. Bandyopadhyay, J. Parmar, and K.V. Ramani Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India Emerg. Infect. Dis. 14 3 2008 412 415
24. T.E. Morrison Reemergence of chikungunya virus J. Virol. 88 2014 11644 11647
25. K. Plante, E. Wang, C.D. Partidos, J. Weger, R. Gorchakov, K. Tsetsarkin, E.M. Borland, A.M. Powers, R. Seymour, D.T. Stinchcomb, J.E. Osorio, I. Frolov, and S.C. Weaver Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism PLoS Pathog. 7 2011 e1002142
26. L. Pohjala, A. Utt, M. Varjak, A. Lulla, A. Merits, T. Hola, and P. Tammela Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays PLoS One 6 2011 e28923
27. K. Ramsauer, M. Schwameis, C. Firbas, M. Mullner, R.J. Putnak, S.J. Thomas, P. Despres, E. Tauber, B. Jilma, and F. Tangy Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial Lancet Infect. Dis. 15 5 2015 519 527
28. C.J. Roy, A.P. Adams, E. Wang, K. Plante, R. Gorchakov, R.L. Seymour, H. Vinet-Oliphant, and S.C. Weaver Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose J. Infect. Dis. 209 2014 1891 1899
29. N.E. Rulli, M.S. Rolph, A. Srikiatkhachorn, S. Anantapreecha, A. Guglielmotti, and S. Mahalingam Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis J. Infect. Dis. 204 2011 1026 1030
30. C. Schilte, T. Couderc, F. Chretién, M. Sourisseau, N. Gangneux, F. Guivel-Benhassine, A. Kraxner, J. Tschopp, S. Higgs, A. Michault, F. Arenzana-Seisdedos, M. Colonna, L. Peduto, O. Schwartz, M. Lecuit, and M.L. Albert Type I IFN controls chikungunya virus via its action on non-hematopoietic cells J. Exp. Med. 207 2 2010 429 442
31. C. Schilte, F. Staikowsky, T. Couderc, Y. Madec, F. Carpentier, S. Kassab, M.L. Albert, M. Lecuit, and A. Michault Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study PLoS Negl. Trop. Dis. 7 3 2013 e2137
32. M.-K. Soumahoro, P.-Y. Boelle, B.-A. Gauzere, K. Atsou, C. Pelat, B. Lambert, G. La Ruche, M. Gastellu-Etchegorry, P. Renault, M. Sarazin, Y. Yazdanpanah, A. Flahault, D. Malvy, and T. Hanslik The chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study PLoS Negl. Trop. Dis. 5 6 2011 e1197
33. F. Staikowsky, F. Talarmin, P. Grivard, A. Souab, I. Schuffenecker, K. le Roux, M. Lecuit, and A. Michault Prospective study of Chikungunya virus acute infection in the Island of La Reunion during the 2005-2006 outbreak PLoS One 4 10 2009 e7603
34. S.D. Thiberville, V. Boisson, J. Gaudart, F. Simon, A. Flahault, and X. de Lamballerie Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean PLoS Negl. Trop. Dis. 7 1 2013 e2004
35. S.D. Thiberville, N. Moyen, L. Dupuis-Maguiraga, A. Nougairede, E.A. Gould, P. Roques, and X. de Lamballerie Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy Antiviral Res. 99 3 2013 Sep 345 370
36. I. Tretyakova, J. Hearn, E. Wang, S. Weaver, and P. Pushko DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice J. Infect. Dis. 209 2014 1882 1890
37. E. Wang, E. Volkova, A.P. Adams, N. Forrester, S.Y. Xiao, I. Frolov, and S.C. Weaver Chimeric alphavirus vaccine candidates for chikungunya Vaccine 26 2008 5030 5039
38. S.C. Weaver, and N.L. Forrester Chikungunya: evolutionary history and recent epidemic spread Antiviral Res. 120 2015 32 39
39. Zakaib, G.D. Virologists form Global Virus Response Network. Nature News Blog, 3 March 201l (accessed March 23, 2015).